Science4Life – The Dresden RecTech Team has successfully participated in the competition again

The Dresden start-up project RecTech led by Prof. Frank Buchholz and Dr. Anne-Kristin Heninger emerged as one of the winners at the Science4Life TechSLAM on May 11, 2021. Within this competition, 20 start-up teams presented their business idea in a … Continue reading

Posted in Uncategorized | Comments Off

The tailored genome – How enzymes can help to cure hereditary diseases

The start-up project RecTech led by Prof. Frank Buchholz and Dr. Anne-Kristin Heninger has once again succeeded in scoring points in the prestigious Science4Life Venture Cup. This time, RecTech was awarded as one of the ten best teams for its … Continue reading

Posted in Uncategorized | Comments Off

The start-up RecTech is one of the winners in the ideas phase of the Science4Life Venture Cup 2021

Within the business plan competition of the Science4Life Venture Cup 2021, 97 applicants presented their innovative business ideas and 5 teams were awarded with a prize for the best business idea. The BMBF-GO-Bio-funded start-up project RecTech, led by Prof. Dr. … Continue reading

Posted in Uncategorized | Comments Off

Master Switch for cancer immunotherapy identified

In the human body, cells are regularly transforming to early stages of a malignancy. These neoplasms are typically recognized and eliminated by immune cells. Only neoplasms that escape from the surveillance of the immune system develop into a clinically relevant … Continue reading

Posted in Uncategorized | Comments Off

Development of a powerful gene editing tool to correct a genomic inversion frequently found in Hemophilia A

Hemophilia A (HA) is the most commonly occurring inheritable deficiency of blood coagulation. Severely affected individuals suffer frequent spontaneous haemorrhaging, which can lead to chronic painful and debilitating arthropathies, hematomas, and potentially life-threatening internal bleeding. About 50% of severe HA … Continue reading

Posted in Uncategorized | Comments Off